Trial · NCT02426112
Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children
NCT02426112, Phase 3, Completed, London School of Hygiene and Tropical Medicine
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children. Trials, record NCT02426112. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02426112
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children
- NCT number
- NCT02426112
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 347 participants, actual
- Lead sponsor
- London School of Hygiene and Tropical Medicine
- Conditions
- Chronic Lung Disease, HIV Infection
- Interventions
- Azithromycin, Placebo
- First posted
- 2015-04-24
- Last updated
- 2019-10-09
Source ClinicalTrials.gov
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Forced Expiratory Volume in one second z score (FEV1) | 12 months | Change in FEV1after 12 months of initiation of therapy with azithromycin |
| Secondary | Forced Expiratory Volume in one second z score (FEV1) | 24 months | Mean change in FEV1 24 months after treatment initiation with azithromycin |
| Secondary | Time to death | 12 months | Time to death 12 months after treatment initiation with azithromycin |
| Secondary | Time to first acute exacerbation | 12 months | |
| Secondary | Number of hospitalizations | 12 and 24 months | |
| Secondary | Number of exacerbations | 12 and 24 months | |
| Secondary | Quality of life scores | 12 and 24 months | |
| Secondary | Mean change in weight-for-age z-score | 12 and 24 months | |
| Secondary | Number of mild, moderate and severe adverse events | 12 months | |
| Secondary | Number of Malaria episodes (Malawi only) | 12 months |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers10
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02426112
GET https://conductscience.org/api/trials/v1/NCT02426112/registered